Pharmaceuticals · Sales VP · Long Time No Contact
Follow-Up for Pharmaceuticals Sales VP: Long Time No Contact
Use this follow-up template when you're emailing a Sales VP in Pharmaceuticals (long time no contact). The thread is months old. They may not remember you. You need a reason that belongs to this week, not nostalgia. Keep the note aligned with Crisp and commercial. They can handle a direct ask.
Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors
We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.
Sources: HubSpot sales email benchmarks; Gong follow-up research
Why does this follow-up work for a Pharmaceuticals Sales VP?
- Offer an exit so the email doesn't feel like a trap.
- Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
- Fits how a sales VP actually reads: 70 to 90 words. Lead with the outcome.
- Bring a new observation about their world, then offer a small, optional next step.
- Name a specific pain instead of 'circling back' with no payload.
When should I send this to a Pharmaceuticals Sales VP?
Give it 3 to 5 business days after the last note before you ping again. Send when you have a real trigger: news, a useful artifact, a role change, a season. For this combo, treat "Only when you have a trigger" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a sales VP, 70 to 90 words. Lead with the outcome.
What this Sales VP actually cares about
A sales VP in Pharmaceuticals is protecting quota, forecast credibility, and rep time. They think in pipeline, ramp, and forecast risk. If you can't map your email to a number they already report, it feels like a hobby. The hook that earns a look is a stage in the funnel that's leaking, a slow follow-up SLA, or a ramp problem. The ask should stay at this size: a 15-minute look at one metric, not a platform tour. Delete trigger: Telling them how to sell. They've heard it. They think in pipeline, ramp, and forecast risk. If you can't map your email to a number they already report, it feels like a hobby.
How Pharmaceuticals changes the note
Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Proof that lands: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft.
How should I customize this template before I send it?
- Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
- Keep the tone crisp and commercial.
- Match their channel. If they live in Slack, don't keep emailing.
- Time it for Only when you have a trigger. Send when you have a real trigger: news, a useful artifact, a role change, a season.
- Don't use consumer-startup slang. It's a credibility leak.
What mistakes should I avoid with this long time no contact note?
- The fastest way to get ignored is stacking three asks into one nudge.
- Don't open with 'it's been a while' and then paste the old pitch.
- Don't use consumer-startup slang. It's a credibility leak.
- Telling them how to sell. They've heard it.
How does this long time no contact scenario compare?
| Dimension | For this template |
|---|---|
| Best send window | Only when you have a trigger |
| Ideal length | 70 to 90 words. Lead with the outcome. |
| Primary ask | a 15-minute look at one metric, not a platform tour |
| Industry metric to cite | time through MLR, access, and compliant engagement rates |
| Tone | Crisp and commercial. They can handle a direct ask. |
| Unlike no response | This isn't a 4-day bump. It's a re-introduction with a new reason. |
| Unlike breakup | You're opening a door, not closing one. Still keep it easy to ignore. |
What should I copy and send?
Copy-ready template
Subject
Sales VP question on long time no contact
Body
Hi [First Name], Wanted to reconnect while [topic] is still fresh. The version of this that matters for commercial, medical, and ops leads who work under review boards and long timelines is cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. If the timing is off, that's useful to know too. I can pause and come back when [trigger event] hits. Given this is long time no contact, ask if the old problem still exists, or if you should leave it archived. Want me to send a 4-bullet recap instead of hopping on a call? Best, [Your Name] [Your Title] [Your Company]
Questions people ask before they hit send
Lead with time through MLR, access, and compliant engagement rates. That's the language this buyer already reports. If you can't connect your email to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick, you're asking them to do the translation work. They won't.
Related templates
Want a custom draft instead? Try the email generator.